Table 1.
Disease | Epigenetic mechanism | Affected gene | References |
---|---|---|---|
Respiratory diseases | |||
LRTIs | Increased susceptibility and mortality of males, since estrogens regulate lncRNAs, which interact with NOS-3 that enhances macrophage-mediated killing of bacteria | [32] | |
COVID-19 | Increased susceptibility and mortality of males, due to estrogen contribution to viral defense and decreased gene methylation in males | ACE2 | [44] |
Asthma | Increased incidence in pre-adolescent males and post-adolescent females, due to sex and age-related changes in gene methylation | SIRPD, IFRD1 | [55, 56] |
COPD | Decreased gene methylation in males | KRT77 | [59] |
PAH | Increased susceptibility in females, due to estrogen-mediated increase in gene methylation | Ephx2 | [60] |
Autoimmune diseases | |||
IBD, MS, RA, SLE | Increased susceptibility in females, due to estrogen-mediated control of immune responses, abnormal silencing of X-linked genes and X-linked miRNA expression (miR106A, miR-17-92, miR-18b, miR-223) | IL-1R/2R/3R, IL-13, TLR7, IRAK1, FOXP3, GATA1, CD40L, IL-10, CXCR3 | [61] |
Gastrointestinal diseases | |||
HCC and liver fibrosis | Increased susceptibility in males due to increased histone methylation in males, causing gene silencing | Cyp, Sult, H19, Igf2, miR675 | [91] |
Neuropsychiatric diseases | |||
ASD |
Increased incidence in males due to: Decreased ASD-related gene methylation and thus increased expression |
[93] | |
Expression of Y-linked genes escaping inactivation | KDM5C, NLGN4 | [94] | |
MDD | Increased incidence in females, due to increased gene methylation and thus decreased gene expression of anti-MDD genes | [93] | |
AD |
Increased incidence in males due to: Decreased gene inactivation in females |
KDM6A, PCDH11X | [98] |
Hypomethylation of genes in males | Aurora kinase C | [103] | |
Reduced HDAC2 levels in females | [103] | ||
Cancer | |||
43 cancer types including glioblastoma | Decreased incidence and mortality of some cancer types, e.g., glioblastoma in females due to tumor suppressor genes escaping XCI | CNKSR2, ATRX, DDX3X, KDM6A, KDM5C, MAGEC3 | [105] |
Breast and ovarian cancer | Increased susceptibility in females due to dysregulation of the Xist RNA expression and repressive marks, causing gene expression imbalances | ATRX | [111] |
Stomach and esophageal cancer | Increased susceptibility in females due to gene mutations, hindering interaction with ATM protein kinase to ensure efficient DNA damage response and repair | EP400 | [112] |